ShanghaiJune 25, 2026 /PRNewswire/ — On June 24, 2026, the highly anticipated 17th Annual Meeting of the New Champions of the World Economic Forum (Summer Davos Forum) grandly opened in Dalian. This year’s forum focuses on the implementation of cutting-edge technology in the real economy and the collaborative upgrading of global industries.Over 1,700 representatives from global political, business, and academic circles gathered together.
As a 2026 World Economic Forum “Young Global Leader,” Cynthia Chen, Chairwoman and President of Pulmart Medical, attended this grand event. During the summit, she actively participated in multiple core dialogues as a guest, adopting a global perspective, focusing on the ecosystem construction of cutting-edge medical technology and the cross-border integration of diverse leadership, profoundly interpreting outstanding leadership driven by innovation, inclusivity, and resilience to the world.
Aligning with Macro Strategic Directions Reshaping Global Treatment Paradigms with Original Hardcore Technology
Innovation-driven development is the key to long-term economic and industrial prosperity. True innovation that changes the world and benefits the world should always be innovation that goes global and embraces the world. Against this backdrop, enhancing the original innovation capabilities of medical devices, bridging the “Darwinian Sea” from laboratory to commercial application, and achieving a high level of global advancement is the mission of every tech enterprise.
Facing the global public health challenges in pulmonary hypertension and heart failure, Pulmart Medical actively responds to the profound call for high-quality development, consistently adhering to long-termism, driven by clinical value, and deeply cultivating the field of cardiopulmonary and vascular critical care. Drawing on Pulmart Medical’s practical experience in advancing innovative therapies globally, Cynthia deeply engaged in discussions on core industry topics such as making medical innovation accessible and breaking down silos between healthcare, government, and enterprises. Together with leaders from various sectors, she explored how to dismantle industry barriers, create a closed-loop ecosystem spanning research, regulation, and industry, and enable cutting-edge original achievements with robust clinical evidence to cross borders and truly benefit patients worldwide.
Gathering Pioneer Forces, Expanding Global Cooperation Ecosystem
The high-quality development of medical innovation relies not only on hardcore breakthroughs in underlying technology but also on an inclusive global ecosystem. Cynthia, with her new identity as a “Young Global Leader” and a female perspective, deeply participated in core dialogues at Davos. She attended an exclusive closed-door breakfast meeting ahead of the Asia-Pacific Economic Cooperation (APEC) Leaders’ Summit, co-hosted by the South China Morning Post and Hong Kong Investment Corporation (HKIC). This roundtable brought together Hong Kong Exchanges and Clearing Chairman Carlson Tong, HKIC CEO Clara Chan, and others, including core political and economic leaders and top global corporate executives. In this high-level dialogue, Cynthia, drawing on the overseas expansion and development needs of Chinese medical technology companies, focused on exchanging views with guests on achieving more efficient business layouts within the global industrial chain and innovation ecosystem.
In line with this year’s Summer Davos Forum’s profound call for “scaling innovation” and global industrial collaborative upgrading, Pulmart Medical will always remain global, driving the scaled implementation of innovative achievements with original cutting-edge technology, continuously expanding the boundaries of life in the field of cardiopulmonary and vascular critical care, and providing tens of millions of patients worldwide with more accessible and affordable “innovation dividends” from China.